Maternal buspirone protects against the adverse effects of in utero stress on emotional and pain-related behaviors in offspring

Physiology and Behavior

Volumn 102, Issue 2, 2011, Pages 137-142

  Butkevich, I ^a   Mikhailenko, V ^a   Vershinina, E ^a   Semionov, P ^a   Makukhina, G ^a   Otellin, V ^a  

^a PAVLOV INSTITUTE OF PHYSIOLOGY   (Russian Federation)

Author keywords

Adult rats; Buspirone; Prenatal stress; The forced swim test; The formalin test; Tonic pain

Indexed keywords

BUSPIRONE; FORMALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CLINICAL EVALUATION; CONTROLLED STUDY; DEPRESSION; EMOTIONAL STABILITY; FEMALE; FORCED SWIMMING TEST; IMMOBILIZATION; IMMOBILIZATION STRESS; LICKING; MALE; NONHUMAN; PAIN; PRENATAL STRESS; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY; TREATMENT OUTCOME; WEIGHT GAIN;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-ANXIETY AGENTS; BEHAVIOR, ANIMAL; BUSPIRONE; EMOTIONS; FEMALE; MALE; PAIN; PAIN MEASUREMENT; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, WISTAR; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 78649329162     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2010.10.023     Document Type: Article

References (78)

1. Darnaudéry M., Maccari S. Epigenetic programming of the stress response in male and female rats by prenatal restraint stress. Brain Res 2008, 57:571-585. Rev.
2. Huizink A.C., Mulder E.J., Buitelaar J.K. Prenatal stress and risk for psychopathology: specific effects or induction of general susceptibility?. Psychol Bull 2004, 130:115-142.
3. Rice F., Harold G.T., Boivin J., van den Bree M., Hay D.F., Thapar A. The links between prenatal stress and offspring development and psychopathology: disentangling environmental and inherited influences. Psychol Med 2010, 40:335-345.
4. Seckl J.R. Glucocorticoids, developmental 'programming' and the risk of affective dysfunction. Progr Brain Res 2008, 167:17-34.
5. Van den Hove D.L., Kenis G., Steinbusch H.W., Blanco C.E., Prickaerts J. Maternal stress-induced reduction in birth weight as a marker for adult affective state. J Front Biosci 2010, 2:43-46. (Elite Ed.).
6. Weinstock M. The role of prenatal stress in the programming of behavior. Perinatal Programming: Early Life Determinants of Adult Health and Disease 2006, 241-252. Taylor and Francis, London, New York. D.M. Hodgson, C.L. Coe (Eds.).
7. Weinstock M. Intrauterine factors as determinants of depressive disorder. Isr J Psychiatry Relat Sci 2010, 47:36-45.
8. Butkevich I.P., Mikhailenko V.A., Vershinina E.A., Khozhai L.I., Grigorev I.P., Otellin V.A. Reduced serotonin synthesis during early embryogeny changes effect of subsequent prenatal stress on persistent pain in the formalin test in adult male and female rats. Brain Res 2005, 1042:144-159.
9. Butkevich I.P., Mikhailenko V.A., Khozhai L.I., Otellin V.A. Pain sensitivity during ontogeny and long-term effects of prenatal noxious events. Perinatal Programming: Early Life Determinants of Adult Health and Disease 2006, 211-222. Taylor and Francis, New York, London. D.M. Hodgson, C.L. Coe (Eds.).
10. Otellin V.A., Khozhai L.I., Ordyan N.E. Prenatal Stress-Treatments and Developing Brain. Adaptive Mechanisms, Immediate and Delayed Effects 2007, St. Petersburg, Desyatka, (In Russian).
11. Butkevich I.P., Miihailenko V.A., Vershinina E.A., Semionov P.O., Otellin V.A., Aloisi A.M. Heterogeneity of the infant stage of rat development: Inflammatory pain response, depression-related behavior, and effects of prenatal stress. Brain Res 2009, 1286:53-59.
12. Clauw D., Ablin J.N. The relationship between "stress" and pain: Lessons learned from fibromyalgia and related conditions. Current Topics in Pain: 12th World Congress on Pain 2009, 245-270. IASP Press, Seattle. J. Castro-Lopes (Ed.).
13. Mico J.A., Berrocoso E., Ortega-Alvaro A., Gibert-Rahola J., Rojas-Corrales M.O. The role of 5-HT1A receptors in research strategy for extensive pain treatment. Curr Top Med Chem 2006, 6:1997-2003.
14. Praag, van H.M. Can stress cause depression?. World J Biol Psychiatry 2004, 6(Suppl. 2):5-22.
15. Smith G.R. The epidemiology and treatment of depression when it coexists with somatoform disorders, somatization, or pain. Gen Hosp Psychiatry 1992, 14:265-272.
16. Savitz J., Lucki I., Drevets W.C. 5-HT(1A) receptor function in major depressive disorder. Progr Neurobiol 2009, 88:17-31.
17. Van den Hove D.L., Lauder J.M., Scheepens A., Prickaerts J., Blanco C.E., Steinbusch H.W. Prenatal stress in the rat alters 5-HT1A receptor binding in the ventral hippocampus. Brain Res 2006, 1090:29-34.
18. Stahl S., Briley M. Understanding pain in depression. Hum Psychopharmacol 2004, 19(Suppl 1):S9-S13.
19. Zoli A., Ferlisi E.M., Massafra V., Mirone L., Barini A., Scuderi F., et al. ACTH, cortisol and prolactin in active rheumatoid arthritis. Clin Rheumatol 2002, 21:289-293.
20. Whitaker-Azmitia P.M., Druse M., Walker P., Lauder J.M. Serotonin as a developmental signal. Behav Brain Res 1996, 73:19-29.
21. Whitaker-Azmitia P.M., Azmitia E.C. Autoregulation of fetal serotonergic neuronal development: role of high affinity serotonin receptors. Neurosci Lett 1986, 67:307-312.
22. Whitaker-Azmitia P.M., Shemer A.V., Caroso J., Molino L., Azmitia E.C. Role of high affinity serotonin receptors in neuronal growth. Ann NY Acad Sci 1990, 600:315-330.
23. Hillion J., Milne-Edwards J.B., Catelon J., de Vitry F., Gros F., Hamon M. Prenatal developmental expression of rat 5-HT1A receptor gene followed by PCK{cyrillic}. Biochem Biophys Res Commun 1993, 191:991-997.
24. Bell J., Zhang X.N., Whitaker-Azmitia P.M. 5-HT3 receptor-active drugs alter development of spinal serotonergic innervation: lack of effect of other serotonergic agents. Brain Res 1992, 571:293-297.
25. Doak G.J., Sawynok J. Formalin-induced nociceptive behavior and edema: involvement of multiple peripheral 5-hydroxytryptamine receptor subtypes. Neuroscience 1997, 80:939-949.
26. Pazos A., Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin1 receptors. Brain Res 1985, 346:205-230.
27. Ferrari P.F., Lowther S., Tidbury H., Greengrass P., Wilson C.A., Horton R.W. The influence of gender and age on neonatal rat hypothalamic 5-HT1A and 5-HT2A receptors. Cell Mol Neurobiol 1999, 19:775-784.
28. Jacobs B.L., Azmitia E.C. Structure and function of the brain serotonin system. Physiol Rev 1992, 72:165-229.
29. Kim J.A., Gillespie R.A., Druse M.J. Effects of maternal ethanol consumption and buspirone treatment on 5-HT1A and 5-HT2A receptors in offspring. Alcoholism. Clin Exp Res 1997, 21:1169-1178.
30. Tajuddin N.F., Druse M.J. A persistent deficit of serotonin neurons in the offspring of ethanol-fed dams: protective effects of maternal ipsapirone treatment. Dev Brain Res 2001, 129:181-188.
31. Druse M.J., Tajuddin N.F., Gillespie R.A., Le P. The effects of ethanol and the serotonin(1A) agonist ipsapirone on the expression of the serotonin(1A) receptor and several antiapoptotic proteins in fetal rhombencephalic neurons. Brain Res 2006, 1092:79-86.
32. Ohlsen R.I., Pilowsky L.S. The place of partial agonism in psychiatry: recent developments. J Psychopharmacol 2005, 19:408-413.
33. Taylor D.P. Buspirone, a new approach to the treatment of anxiety. FASEB J 1988, 2:2445-2452.
34. Wieland S., Lucki I. Antidepressant-like activity of 5-HT(1A) agonists measured with the forced swim test. Psychopharmacology 1990, 101:497-504.
35. Akimova E., Lanzenberger R., Kasper S. The serotonin-1A receptor in anxiety disorders. Biol Psychiatry 2009, 66:627-635.
36. Blier P., Ward N.M. Is there a role for 5-HT1A agonists in the treatment of depression?. Biol Psychiatry 2003, 53:193-203.
37. Lucki I. Behavioral studies of serotonin receptor agonists as antidepressant drugs. J Clin Psychiatry 1991, 52:24-31.
38. Giordano J., Rogers L. Putative mechanisms of buspirone-induced antinociception in the rat. Pain 1992, 50:365-372.
39. Bragin E.O., Korneev A.Y., Vasilenko G.F. Buspirone effect on the development of antinociceptive reactions. Pain 1989, 36:257-261.
40. Sivarao D.V., Newberry K., Lodge N.J. Effect of the 5HT1A receptor partial agonist buspirone on colorectal distension-induced pseudoaffective and behavioral responses in the female Wistar rat. Eur J Pharmacol 2004, 494:23-29.
41. Pavlakovic G., Tigges J., Crozier A. Effect of buspirone on thermal sensory and pain thresholds in human volunteers. BMC Clin Pharmacol 2009, 9:12. 10.1186/1472-6904-9-12.
42. Morley-Fletcher S., Darnaudery M., Koehl M., Casolini P., Van Reeth O., Maccari S. Prenatal stress in rats predicts immobility behavior in the forced swim test. Effects of a chronic treatment with ianeptine. Brain Res 2003, 989:246-251.
43. Lauder J.M., Krebs H. Serotonin as a differentiation signal in early neurogenesis. Dev Neurosci 1978, 1:15-30.
44. Wang Q.P., Nakai Y. The dorsal raphe: an important nucleus in pain modulation. Brain Res Bull 1994, 34:575-585.
45. Jutapakdeegul N., Afadlal S., Polaboon N., Phansuwan-Pujito P., Govitrapong P. Repeated restraint stress and corticosterone injections during late pregnancy alter GAP-43 expression in the hippocampus and prefrontal cortex of rat pups. Int J Dev Neurosci 2010, 28:83-90.
46. Hajos M., Richards C.D., Szekely A.D., Sharp T. An electrophysiological and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat. Neuroscience 1998, 87:95-108.
47. Jankowski M.P., Sesack S.R. Prefrontal cortical projections to the rat dorsal raphe nucleus: ultrastructural features and associations with serotonin and gamma-aminobutyric acid neurons. J Comp Neurol 2004, 468:518-529.
48. Puig M.V., Artigas F., Celada P. Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: involvement of serotonin and GABA. Cereb Cortex 2005, 15:1-14.
49. Lim L.W., Temel Y., Sesia T., Vlamings R., Visser-Vandewalle V., Steinbusch H.W., et al. Buspirone induced acute and chronic changes of neural activation in the periaqueductal gray of rats. Neuroscience 2008, 155:164-173.
50. Lim L.W., Temel Y., Visser-Vandewalle V., Steinbusch H., Schruers K., Hameleers R., et al. Effect of buspirone on the behavioral regulation of rats in low versus high anxiety conditions. Arzneimittelforschung 2008, 58:269-276.
51. Boyd A. Psychiatric nursing: contemporary practice 2008, Wolters Kluwer Health/Lippincott Williams &Wilkins, Philadelphia.
52. Yuen E.Y., Jiang Q., Chen P., Gu Z., Feng J., Chen T.J. Association study of two serotonin 1A receptor gene polymorphisms and fluoxetine treatment response in Chinese major depressive disorders. Eur Neuropsychopharmacol 2006, 16:498-503.
53. Holmes A. Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease. Neurosci Biobehav Rev 2008, 32:1293-1314.
54. Kitamura Y., Nagatani T. Buspirone enhances immobility in the forced swim test in mice. Pharmacol Biochem Behav 1996, 55:445-451.
55. Cervo L., Grignashi G., Samanin R. Different effects of intracerebral and systemic administration of buspirone in the forced swimming test: Involvement of a metabolite. Life Sci 1988, 43:2095-2102.
56. Przegaliriski E., Tatarczyfiska E., Chojnacka-Wbjcik E. Antidepressant-like activity of ipsapirone, buspirone and gepirone in the forced swimming test in rats pretreated with proadifen. J Psychopharmacol 1990, 4:204-209.
57. Nishio H., Kasuga S., Ushijima M., Harada Y. Prenatal stress and postnatal devopment of neonatal rats -sex-dependent effects on emotional behavior and learning ability of neonatal rats. Int J Dev Neurosci 2001, 19:37-45.
58. Kivistö K.T., Laitila J., Mårtensson K., Neuvonen P.J. Determination of buspirone and 1-(2-pyrimidinyl)-piperazine (1-PP) in human plasma by capillary gas chromatography. Ther Drug Monit 1999, 21:317-321.
59. Cimino M., Ponzio F., Achilli G., Vantini G., Perego C., Algeri S., et al. Dopaminergic effects of buspirone, a novel anxiolytic agent. Biochem Pharmacol 1983, 32:1069-1074.
60. Rimeli T.J., Henry D.E., Lee D.K.H., Geiger G., Heaslip R.J., Grimes D. Tissue-dependent alpha adrenoceptor activity of buspirone and related compounds. J Pharmacol Exp Ther 1987, 241:771-778.
61. Gebhart G.F. Descending modulation of pain. Neurosci Biobehav Rev 2004, 27:729-737.
62. Oyama T., Ueda M., Kuraishi Y., Akaike A., Satoh M. Dual effect of serotonin on formalin-induced nociception in the rat spinal cord. Neurosci Res 1996, 25:129-135.
63. Hunt S.P., Suzuki R., Rahman W., Dickenson A.H. Chronic pain and descending facilitation. Proc. of the 11th World Congress on Pain 2006, 349-363. IASP Press, Seattle. H. Flor, E. Kalso, J.O. Dostrovsky (Eds.).
64. Harvey K.V., Balon R. Augmentation with buspirone: a review. Ann Clin Psychiatry 1995, 7:143-147.
65. Albert P.R., Francois B.L. Modifying 5-HT1A receptor gene expression as a new target for antidepressant therapy. Front Neurosci 2010, 4:1-7. Article 35.
66. Magni G. The use of antidepressants in the treatment of chronic pain. A review of the current evidence. Drugs 1991, 42:730-748.
67. Cai Q., Zhu Z.L., Fan X.L., Jia N., Bai Z.L., Song L., et al. The effects of prenatal stress on Ca2+ channel and K+channel of hippocampal CA3 pyramidal neurons in rat offspring. Fen Zi Xi Bao Sheng Wu Xue Bao 2006, 39:223-228.
68. Liang J.-H., Wang X.-H., Liu R.-K., Sun H.-L., Ye X.-F., Zheng J.-W. Buspirone-induced antinociception is mediated by L-type calcium channels and calcium/caffeine-sensitive pools in mice. Psychopharmacology 2003, 166:276-283.
69. Biała G. Antidepressant-like properties of some serotonin receptor ligand and calcium channel antagonists measured with the forced swimming test in mice. Pol J Pharmacol 1998, 50:117-124.
70. Secher A., Bukh J., Bock C., Koefoed P., Rasmussen H.B., Werge T., et al. Antidepressive-drug-induced bodyweight gain is associated with polymorphisms in genes coding for COMT and TPH1. Int Clin Psychopharmacol 2009, 4:199-203.
71. Kim J.A., Druse M.J. Protective effects of maternal buspirone treatment on serotonin reuptake sites in ethanol-exposed offspring. Dev Brain Res 1996, 92:190-198.
72. Ward I.L., Weisz J. Differential effects of maternal stress on circulating levels of corticosterone, progesterone, and testosterone in male and female rat fetuses and their mothers. Endocrinology 1984, 114:1635-1644.
73. Deminière J.M., Piazza P.V., Guegan G., Abrous N., Maccari S., Le Moal M., et al. Increased locomotor response to novelty and propensity to intravenous amphetamine self-administration in adult offspring of stressed mothers. Brain Res 1992, 586:135-139.
74. Porsolt R.D., LePichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
75. Dubuisson D., Dennis S.G. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine and brain stimulation in rats and cats. Pain 1977, 4:161-174.
76. Wheeler-Aceto H., Cowan A. Standardization of the rat paw formalin test for the evaluation of analgesics. Psychopharmacology 1991, 104:35-44.
77. Capone F., Aloisi A.M. Refinement of pain evaluation techniques. The formalin test. Ann 1st Super Sanità 2004, 40:223-229.
78. Butkevich I.P., Vershinina E.A. Maternal stress differently alters nociceptive behaviors in the formalin test in adult female and male rats. Brain Res 2003, 961:159-165.